Atezolizumab vs Clindamycin

## Atezolizumab vs Clindamycin: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Clindamycin**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

**Clindamycin**: Binds 50S ribosomal subunit inhibiting protein synthesis.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Clindamycin — 2-3 hours.

## Chemical Properties

**Molecular Formula**: Atezolizumab — N/A; Clindamycin — C18H33ClN2O5S.

**Molecular Weight**: Atezolizumab — N/A; Clindamycin — 424.9830 g/mol.

**Type**: Atezolizumab — Antibody; Clindamycin — Small molecule.